Member Info for Matml74

Computer909, You should probably take a read of this then...... https://www.synairgen.com/about-us/synairgens-directors/

Plenty of commercial experience from the Chairman down.

Auction at 24p and trades going through at 24p

Thanks for sharing that research WedMe. Surely all the parts are fitting together now to ensure this drug gets out there ASAP to save lives.

Merc, Well put!! It really is that simple! Sit, wait and watch. I'm more excited to see Scally results than what the price in Monday morning.

Bojo, You should check. DYOR and all that.

Looks like all shares are in sticky hands. No one wants to sell or buy at this level.

Bojo, it was stated by RM in his interview on the 20th July that they would not fill the numbers of patients for this trial until second wave of Covid. Hopefully recruitment has sped up over the past few weeks.

Lets hope so Dibs. At the very least you think there would be some news on the path forward to EUA in the US.

Snowman, It’s wired isn’t it. Should been watched by many more!! Many people/doctors/scientists who have looked at Covid treatments can see that interferon beta shows the most promise as a treatment. The data shows that interferon shows the most promise. Yet still still we wait for approval. Governments seem to have backed the vaccine route but I think as winter approaches with no imminent vaccine available they will realise that this drug needs to be given a chance to help.

Dudio,

The roulette spin was back in March-July. It was definitely black or red back then...... it was a double blind trial. The results on 20th July significantly derisked this share for me. Now it is just a matter of the board getting the data through EUA , of which we much, and the board getting the right deal done to ensure this drug is available as soon as possible.

Pretty sure they will have some decent patent lawyers...

SirSwish..... Trial done with AZN in 2016.

Great post RTB. Sums up the RNS and situation perfectly.

mm's have been manipulating price of this share for months.

Rorkes/Matt,

Stabilising or improving PEFR is a good thing.

"greater variability in daily PEFR measurements in patients with severe to very severe COPD (with similar comorbidities, age, medication use, and symptoms) could help to objectively identify patients with more unstable disease with a propensity for greater exacerbation and a higher mortality."

maybe you should read some of the others then....

Skeletor, I think the rns mainly focussed on the data to support covid EUA. It is an interim analysis and the trial has not even had its full complement of patients yet. It does look as though it will be of benefit for COPD patients so will help out your mum in the event of viral infection.

Interestingly there is no mention of the COVID pivotal trial. I think EUA approval is now a given.

What a great result. Well done to the Synairgen team for all their hard work. Hopefully governments will now pull their finger out and get this drug approved before the winter! Should be an interesting morning!

Lol tommy.

The patients don’t know whether they are on a placebo or the drug!